Clinical trials for Pioglitazone

The European Union Clinical Trials Register allows you to search for protocol and results information on:

interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC

clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
Clinical Trials Information System (CTIS).

The EU Clinical Trials Register currently displays 44339 clinical trials with a EudraCT protocol, of which 7369 are clinical trials conducted with subjects less than 18 years old. The register also displays information on 18700 older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).

Examples: Cancer AND drug name. Pneumonia AND sponsor name.
How to search [pdf]

Advanced Search:

Search tools

Select Country:	Select Age Range:
Select Trial Status:	Select Trial Phase:
Select Gender:
Select Date Range: to
Select Rare Disease:
IMP with orphan designation in the indication
Orphan Designation Number:
Results Status:
Clear advanced search filters

Trials with a EudraCT protocol (193)
Paediatric studies in scope of Art45 of the Paediatric Regulation (0)

193 result(s) found for: Pioglitazone. Displaying page 9 of 10.

EudraCT Number: 2010-021560-15

Sponsor Protocol Number: NN9068-3697

Start Date*: 2011-03-22

Sponsor Name:Novo Nordisk A/S

Full Title: A 26 week randomised, parallel three-arm, open-label, multi-centre, multinational treat-to-target trial comparing fixed ratio combination of insulin degludec and liraglutide versus insulin degludec...

Medical condition: Type 2 diabetes

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	14.0	10027433 - Metabolism and nutrition disorders	10067585	Type 2 diabetes mellitus	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Completed) DE (Completed) IT (Completed) FI (Completed) IE (Completed) SK (Completed) HU (Completed) ES (Completed)

Trial results: View results

EudraCT Number: 2015-005242-60

Sponsor Protocol Number: UoL001187

Start Date*: 2016-10-03

Sponsor Name:University of Liverpool

Full Title: RESILIENT: RandomisEd, controlled, double blind Study to assess mechanistic effects of combination therapy of dapagliflozin with Exenatide QW versus dapagliflozin alone in obese (BMI>30 kg/m2) pati...

Medical condition: Type 2 Diabetes Mellitus

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	19.1	10027433 - Metabolism and nutrition disorders	10067585	Type 2 diabetes mellitus	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (GB - no longer in EU/EEA)

Trial results: (No results available)

EudraCT Number: 2015-002417-29

Sponsor Protocol Number: NN2211-4232

Start Date*: 2016-01-08

Sponsor Name:Novo Nordisk A/S

Full Title: Efficacy in controlling glycaemia with Victoza® (liraglutide) as add-on to metformin vs. OADs as add-on to metformin after up to 104 weeks of treatment in subjects with type 2 diabetes inadequately...

Medical condition: Diabetes Mellitus, Type 2

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	18.1	100000004861	10045242	Type II diabetes mellitus	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: LV (Completed)

Trial results: View results

EudraCT Number: 2006-002311-27

Sponsor Protocol Number: 1218.5

Start Date*: 2006-09-14

Sponsor Name:Boehringer Ingelheim Pharmaceuticals, Inc.

Full Title: A randomized, double-blind, placebo-controlled, five parallel group study investigating the efficacy and safety of BI 1356 BS (0.5 mg, 2.5 mg and 5.0 mg administered orally once daily) over 12 week...

Medical condition: Patients with Type 2 diabetes

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	8.1		10012613	Diabetes mellitus non-insulin-dependent	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: CZ (Completed)

Trial results: View results

EudraCT Number: 2011-000284-27

Sponsor Protocol Number: UOLDR0001N

Start Date*: 2011-05-16

Sponsor Name:University of Leicester

Full Title: A Randomised Controlled Trial for People with Established Type 2 Diabetes during Ramadan: Liraglutide versus a Sulphonylurea and/or Pioglitazone

Medical condition: Type 2 Diabetes Mellitus

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	14.1	10027433 - Metabolism and nutrition disorders	10067585	Type 2 diabetes mellitus	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Completed)

Trial results: View results

EudraCT Number: 2010-021516-42

Sponsor Protocol Number: F3Z-MC-IOQC

Start Date*: 2011-02-07

Sponsor Name:Eli Lilly and Company

Full Title: Two Approaches to Escalate Lispro Therapy in Patients with Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on Basal Insulin Therapy and Oral Agents Alone

Medical condition: type 2 diabetes

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	14.1	10027433 - Metabolism and nutrition disorders	10045242	Type II diabetes mellitus	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: LT (Completed) AT (Completed) FR (Completed) DK (Completed)

Trial results: View results

EudraCT Number: 2005-004597-24

Sponsor Protocol Number: 1218.6

Start Date*: 2006-03-29

Sponsor Name:Boehringer Ingelheim Limited

Full Title: A randomised, double-blind, placebo-controlled, five parallel groups study investigating the efficacy and safety of BI 1356 BS (1mg, 5mg and 10mg administered orally once daily) over 12 weeks as ad...

Medical condition: Patients with type 2 diabetes

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	8.1		10012613	Diabetes mellitus non-insulin-dependent	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Completed) DE (Completed) SE (Completed) SK (Completed)

Trial results: View results

EudraCT Number: 2009-017524-36

Sponsor Protocol Number: DUT-MD-403

Start Date*: 2010-05-18

Sponsor Name:Forest Research Institute, Inc.

Full Title: A Phase III, Multicenter, Double-blind, Active-Controlled, 52-Week Extension Study to Evaluate the Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus Receiving Background ...

Medical condition: Type 2 diabetes mellitus (T2DM)

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	12.1		10045242	Type II diabetes mellitus	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: HU (Completed)

Trial results: View results

EudraCT Number: 2015-005208-26

Sponsor Protocol Number: P13/12

Start Date*: 2016-02-22

Sponsor Name:Centre Hospitalier de Versailles

Full Title: CANDIDATE THERAPIES IN COMBINATION OR SEQUENTIALLY WITH TYROSINE KINASE INHIBITORS IN CHRONIC PHASE CHRONIC MYELOGENOUS LEUKAEMIA (CP-CML) PATIENTS IN COMPLETE CYTOGENETIC RESPONSE WITHOUT ACHIEVIN...

Medical condition: CHRONIC PHASE CHRONIC MYELOGENOUS LEUKAEMIA (CP-CML)

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	19.0	100000004864	10058246	Chronic myelogenous leukaemia	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: FR (Trial now transitioned)

Trial results: (No results available)

EudraCT Number: 2007-000123-18

Sponsor Protocol Number: NN304 - 1833

Start Date*: 2007-08-03

Sponsor Name:Novo Nordisk A/S

Full Title: A randomised, controlled, parallel, open-labelled, multinational, trial comparing the efficacy and safety of step-wise addition of insulin aspart according to the largest meals (Basic Basal Plus re...

Medical condition: type 2 diabetes

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10045242	Type II diabetes mellitus	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: SE (Completed) GB (Completed) DK (Completed) ES (Completed) FI (Completed) FR (Completed) NL (Completed)

Trial results: View results

EudraCT Number: 2014-005639-15

Sponsor Protocol Number: NN9068-4228

Start Date*: 2015-10-20

Sponsor Name:Novo Nordisk A/S

Full Title: A 104 week clinical trial comparing long term glycaemic control of insulin degludec/liraglutide (IDegLira) versus insulin glargine therapy in subjects with type 2 diabetes mellitus

Medical condition: Diabetes Mellitus, Type 2

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	19.0	100000004861	10045242	Type II diabetes mellitus	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Completed) HU (Completed) SK (Completed) CZ (Completed) NO (Completed) PL (Completed) IT (Completed)

Trial results: View results

EudraCT Number: 2009-011128-70

Sponsor Protocol Number: CSOM230G2304

Start Date*: 2011-08-24

Sponsor Name:Novartis Pharma Services AG

Full Title: A randomized, double-blind, multicentre, phase III study to evaluate the efficacy and safety of pasireotide LAR in patients with Cushing’s disease

Medical condition: Cushing's disease

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	14.1	100000004860	10011651	Cushing's disease	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Completed) ES (Completed) DE (Completed) NL (Completed) BE (Completed) PL (Completed) IT (Completed)

Trial results: View results

EudraCT Number: 2011-005206-30

Sponsor Protocol Number: B1621002

Start Date*: 2012-04-17

Sponsor Name:Pfizer Inc., 235 East 42nd Street, New York, NY 10017

Full Title: A PHASE 2, RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED, DOSE-RANGING, PARALLEL GROUP STUDY TO EVALUATE SAFETY AND EFFICACY OF PF-04937319 AND GLIMEPIRIDE IN ADULT PATIENTS WITH TYPE 2 DIABETES M...

Medical condition: Type 2 Diabetes Mellitus (T2DM)

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	14.1	10027433 - Metabolism and nutrition disorders	10045242	Type II diabetes mellitus	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: HU (Completed) BG (Completed) SK (Completed)

Trial results: View results

EudraCT Number: 2009-017266-23

Sponsor Protocol Number: DUT-MD-308

Start Date*: 2010-04-21

Sponsor Name:Forest Research Institute, Inc.

Full Title: A Phase III, Multicenter, Randomized, Double-blind, Placebo-Controlled, Safety Study to Evaluate Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus Treated With Dutogliptin

Medical condition: Type 2 diabetes mellitus (T2DM)

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	12.1		10045242	Type II diabetes mellitus	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: LT (Prematurely Ended) LV (Prematurely Ended) EE (Prematurely Ended)

Trial results: View results

EudraCT Number: 2011-002931-25

Sponsor Protocol Number: GS-US-259-0131

Start Date*: 2012-02-28

Sponsor Name:Gilead Sciences, Inc.

Full Title: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine Monotherapy in Subjects with Type 2 Diabetes Mellitus

Medical condition: Type 2 Diabetes Mellitus

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	14.1	10027433 - Metabolism and nutrition disorders	10067585	Type 2 diabetes mellitus	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: HU (Completed) CZ (Completed) PL (Completed) SK (Completed)

Trial results: View results

EudraCT Number: 2014-000988-41

Sponsor Protocol Number: UoL000977

Start Date*: 2014-08-22

Sponsor Name:University of Liverpool

Full Title: A randomized, controlled multi-centre trial of 26 weeks of subcutaneous Liraglutide (a GLP1 receptor agonist), with or without continuous positive airway pressure (CPAP), in patients with Type 2 Di...

Medical condition: Obstructive Sleep Apnoea and Type 2 Diabetes

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	100000014722	10029983	Obstructive sleep apnoea syndrome	LLT
	20.0	10027433 - Metabolism and nutrition disorders	10067585	Type 2 diabetes mellitus	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Completed)

Trial results: View results

EudraCT Number: 2007-007805-58

Sponsor Protocol Number: KP-MSD-01-08

Start Date*: 2009-11-16

Sponsor Name:Med. Klinik II, Grosshadern, Klinikum der Universität München

Full Title: The effect of sitagliptin on postprandial lipoprotein metabolism in patients with diabetes mellitus type 2

Medical condition: Diabetes mellitus type 2

Disease:	Version	SOC Term	Classification Code	Term	Level
	9.1		10012613	Diabetes mellitus non-insulin-dependent	LLT
	9.1		10012619	Diabetes mellitus poor control	LLT
	9.1		10045242	Type II diabetes mellitus	LLT
	9.1		10063624	Type II diabetes mellitus inadequate control	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Ongoing)

Trial results: (No results available)

EudraCT Number: 2017-003197-13

Sponsor Protocol Number: ISIS484137-CS2

Start Date*: 2017-11-24

Sponsor Name:Ionis Pharmaceuticals, Inc.

Full Title: A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study to Evaluate the Safety, Tolerability and Pharmacodynamics of ISIS 484137 (ISIS-DGAT2RX, an Antisense Inhibitor of Diacylglycerol Acyltr...

Medical condition: Hepatic Steatosis in type 2 diabetes (T2DM)

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	10027433 - Metabolism and nutrition disorders	10067585	Type 2 diabetes mellitus	PT
	20.0	10019805 - Hepatobiliary disorders	10019708	Hepatic steatosis	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: HU (Completed)

Trial results: View results

EudraCT Number: 2007-005061-36

Sponsor Protocol Number: F3Z-EW-S020

Start Date*: 2008-01-25

Sponsor Name:Lilly S.A.

Full Title: Comparación de un régimen de insulina lispro premezclada (proporción baja, 25/75; y proporción media, 50/50) con un régimen de inyecciones separadas de insulina basal y en bolos, en pacientes con d...

Medical condition: Diabetes Mellitus tipo 2

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10063624	Type II diabetes mellitus inadequate control	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: ES (Completed) PT (Completed)

Trial results: View results

EudraCT Number: 2010-019724-30

Sponsor Protocol Number: F3Z-CR-IOQE

Start Date*: 2010-12-17

Sponsor Name:Lilly S.A.

Full Title: Comparación de insulina lispro premezclada (proporción baja) dos veces al día frente a insulina glargina una vez al día e insulina lispro prandial una vez al día, como estrategias de intensificació...

Medical condition: Diabetes tipo 2

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	13		10067585	Diabetes mellitus tipo 2	LLT

Population Age: Adults

Gender: Male, Female

Trial protocol: ES (Completed)

Trial results: View results

Subscribe to this Search
To subscribe to the RSS feed for this search click here

. This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.

Download Options:
Number of Trials to download:

Download Content:

Download Format:


Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.

Query did not match any studies.

For support, Contact us.

The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

European Medicines Agency © 1995-Sat May 31 12:16:22 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands

Austria
Belgium
Bulgaria
Croatia
Cyprus
Czechia
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Liechtenstein
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom
Outside EU/EEA